AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Is your solitaire opponent actually a bot?
2
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
3
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
4
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
5
Silverfort acquires Rezonate for several tens of millions to expand cloud security reach
More news

FSD Pharma

3 stories about FSD Pharma
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma’s Acquisition of Therapix Hits a Snag

12.12.18|Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed

28.11.18|Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases